Spears Abacus Advisors LLC Orchard Therapeutics PLC Transaction History

Spears Abacus Advisors LLC

  • $4.34 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.45 - $0.69 $9,515 - $14,590
21,145 New
21,145 $11,000
Q4 2021

Feb 14, 2022
BUY
$1.16 - $2.23 $8,090 - $15,554
6,975 Added 45.29%
22,375 $30,000
Q3 2021

Nov 15, 2021
BUY
$2.24 - $4.29 $34,496 - $66,066
15,400 New
15,400 $35,000

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email